Suzhou Basecare Medical Corporation Limited (HKG:2170)
Hong Kong · Delayed Price · Currency is HKD
1.930
-0.050 (-2.53%)
Apr 20, 2026, 2:05 PM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
| -75.13M | -51.07M | -17.36M | - | - | | | |
| 128.77M | 201.95M | 163.19M | - | - | | | |
| -36.24% | 23.75% | - | - | - | | | |
| 179.63M | 148.23M | 62.14M | - | - | | | |
| 21.19% | 138.53% | - | - | - | | | |
Sales of Testing Kits and Sales of Testing Devices and Instruments | - | - | - | 140.90M | 107.30M | | | |
Sales of Testing Kits and Sales of Testing Devices and Instruments Growth | - | - | - | 31.32% | 32.29% | | | |
| 233.27M | 299.11M | 207.98M | 140.90M | 107.30M | | | |
| -22.01% | 43.82% | 47.60% | 31.32% | 32.29% | | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
People's Republic of China (PRC) | 119.93M | 201.90M | 163.28M | 140.90M | 107.30M | | | |
People's Republic of China (PRC) Growth | -40.60% | 23.65% | 15.88% | 31.32% | 32.29% | | | |
| 59.24M | 58.43M | 23.92M | - | - | | | |
| 1.38% | 144.28% | - | - | - | | | |
| 33.75M | 21.33M | 13.73M | - | - | | | |
Asia (excluding The Prc) Growth | 58.25% | 55.33% | - | - | - | | | |
| 20.35M | 17.45M | 7.05M | - | - | | | |
| 16.61% | 147.60% | - | - | - | | | |
| 233.27M | 299.11M | 207.98M | 140.90M | 107.30M | | | |
| -22.01% | 43.82% | 47.60% | 31.32% | 32.29% | | | |
Source: S&P Global Market Intelligence.